Dieter Falkenburg
Vorstandsvorsitzender bei Novoplant GmbH
Aktive Positionen von Dieter Falkenburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Vorstandsvorsitzender | - | - |
Karriereverlauf von Dieter Falkenburg
Ehemalige bekannte Positionen von Dieter Falkenburg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
ASTA Medica Oncology | Corporate Officer/Principal | - | - |
Ausbildung von Dieter Falkenburg
Ruprecht-Karls-Universität Heidelberg | Doctorate Degree |
Statistik
International
Deutschland | 3 |
Vereinigte Staaten | 2 |
Operativ
Chief Executive Officer | 1 |
Doctorate Degree | 1 |
Corporate Officer/Principal | 1 |
Sektoral
Process Industries | 2 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 2 |
---|---|
Novoplant GmbH
Novoplant GmbH Agricultural Commodities/MillingProcess Industries Novoplant GmbH develops and provides veterinary medicines. It produces antibodies and antibody fragments in plants for veterinary use to fight intestinal pathogens. It received a license for the development and commercialization of therapeutic antibodies as feed components for use in veterinary medicine. It will use MorphoSys’s HuCAL GOLD technology to generate antibodies against viruses, parasites and pathogenic microorganisms. The addition of such antibodies to animal feed stock may offer protection against infectious diseases in the respective animal’s gastro-intestinal tract. The company was founded in 1998 and is headquartered in Gatersleben, Germany. | Process Industries |
ASTA Medica Oncology |
- Börse
- Insiders
- Dieter Falkenburg
- Erfahrung